首頁 › 神經膠質瘤 › 加州 › San Francisco
San Francisco, CA 的 神經膠質瘤 臨床試驗
14 項針對 神經膠質瘤 的研究正在 San Francisco（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
招募中1/2 期
- Research Site, San Francisco
MCT for the Harvard/UCSF ROBIN Center
招募中
- University of California, San Francisco, San Francisco
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
招募中1/2 期
- UCSF Medical Center-Mission Bay, San Francisco
Assessing Brain Metabolism Using MRS With Deuterated Glucose
招募中觀察性研究歡迎健康志工
- University of California, San Francisco, San Francisco
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
招募中3 期
- University of California, San Francisco
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
招募中1 期
- University of California, San Francisco, San Francisco
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
招募中2 期
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Imaging of Solid Tumors Using 18F-TRX
招募中1 期
- University of California, San Francisco, San Francisco
Hyperpolarized Imaging in Diagnosing Participants With Glioma
招募中1 期
- University of California, San Francisco, San Francisco
Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma
招募中1 期
- University of California, San Francisco, San Francisco
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
招募中1 期
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
招募中1/2 期
- University of California at San Francisco, San Francisco
DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
招募中1/2 期
- University of California, San Francisco
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
招募中觀察性研究
- University of California, San Francisco (UCSF), San Francisco
其他城市的 神經膠質瘤 試驗
- New York City, NY25 項研究
- Houston, TX23 項研究
- Boston, MA20 項研究
- Washington, DC19 項研究
- Philadelphia, PA16 項研究
- Columbus, OH15 項研究
- Miami, FL15 項研究
- Chicago, IL13 項研究
- Durham, NC12 項研究
- Seattle, WA11 項研究
- St. Louis, MO10 項研究
- Aurora, CO10 項研究
San Francisco 的其他研究
- 前列腺癌45 項研究
- 乳癌43 項研究
- 非小細胞肺癌36 項研究
- 癌症（所有類型）35 項研究
- 心臟衰竭29 項研究
- 轉移性癌症28 項研究
- 肺癌22 項研究
- 黑色素瘤22 項研究
- 胰臟癌20 項研究
- 卵巢癌19 項研究
- 大腸直腸癌18 項研究
- 心血管疾病18 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。